Program Description & Educational Objectives

In this activity, an expert in age-related macular degeneration discusses the importance of regular assessments, including dilated macular examination, in a 67-year-old woman previously diagnosed and treated for AMD and explores the options for diagnosing and managing AMD in a 74-year-old man experiencing straight-line distortion.

Upon completion of this activity, participants should be better able to:

• Explain the rationale for early detection and active follow-up of AMD
• Apply recent efficacy and safety evidence surrounding use of anti-VEGF agents for treatment of neovascular AMD to clinical practice
• Develop individualized treatment plans to minimize visual impairment and blindness in patients with AMD

Target Audience

This activity has been designed to meet the educational needs of retinal specialists and other clinicians involved in the management of patients with macular degeneration.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: September 01, 2010 - August 31, 2012
Time to Complete PeerView inPractice: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Course Director and Interviewee

David M. Brown, MD, FACS
Clinical Associate Professor
Department of Ophthalmology
Weill Cornell Medical College
The Methodist Hospital
Director of Clinical Research at the Greater Houston Retina Research Center
Private Practice at Retina Consultants of Houston
Houston, Texas

David M. Brown, MD, FACS, has a financial interest/relationship or affiliation in the form of:
Consultant for Allergan, Inc.; Genentech, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.
Grant/Research Support from Alcon Laboratories, Inc.; Alimera Sciences; Allergan, Inc.; Eli Lilly and Company; Genentech, Inc.; Jerini AG; Neurotech; NeoVista, Inc., Novartis Pharmaceuticals Corporation; Othera Pharmaceuticals; Pfizer Inc; Regeneron Pharmaceuticals, Inc.; Schering-Plough Corporation; Sirion Therapeutics, Inc.; TargeGen Inc., and ThromboGenics.
Honoraria from Genentech, Inc.; NeoVista, Inc., Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.
Advisory Board for Allergan, Inc. and Genentech, Inc.
Other Financial or Material Support from Editorial board involvement in Retina Today and Retinal Physician.

Content Director

Annette Wiggins
PVI, PeerView Institute for Medical Education, Inc.

Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This CME activity is jointly sponsored by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from Genentech, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.